NCT03831334View on ClinicalTrials.gov

Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 9, 2019

Primary Completion Date

January 24, 2024

Study Completion Date

August 31, 2025

Conditions
Permanent Chemotherapy-induced Alopecia
Interventions
DRUG

oral minoxidil

Participants will be provided with minoxidil (2.5 mg tablets) for 90 days (45 tablets + 5 extra in case of splitting difficulty) of treatment drug in dispensing containers and instructed to take half a pill (1.25mg), once a day.

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER